Indian pharma companies gear up to fight bird flu

Can Cipla do for bird flu what it has already done for Aids?

Quick Poll

Which risk do you perceive as being the most significant for EM investors today?

Previous polls ››

September 2016 Magazine
AsianInvestor Magazine

What's in this issue

Expanding ESG in Asia
Q&A: Jupai Holdings
The Brexit fallout for fund managers
Chinese hedge funds step offshore